Approval · Notice of Compliance 26936 · 2021
NGENLA: Notice of Compliance 26936
Issued October 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26936
- Date
- October 26, 2021
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- SOMATROGON 20 MG per ML
- SOMATROGON 50 MG per ML